This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Winston-Salem, NC (US) (2001)
- New York, NY (US) (2001)
Company Filing History:
Years Active: 2001
Title: Setaluri Vijayasaradhi: Innovator in Cancer Research
Introduction
Setaluri Vijayasaradhi is a notable inventor based in Winston-Salem, NC (US). He has made significant contributions to the field of cancer research, particularly in the development of innovative methods for stimulating immune responses against cancer.
Latest Patents
Vijayasaradhi holds two patents that showcase his groundbreaking work. The first patent is titled "Method and compositions for stimulation of an immune response to a differentiation antigen stimulated by an altered differentiation antigen." This invention addresses how the immune system can be stimulated to respond to self-differentiation antigens through the administration of therapeutic differentiation antigens. The second patent, "gp75 as a tumor vaccine for melanoma," provides an isolated nucleic acid molecule that encodes the amino acid sequence for gp75. This invention also includes vaccines designed to enhance the production of antibodies against gp75, which can be crucial in treating and preventing cancer recurrence.
Career Highlights
Setaluri Vijayasaradhi is affiliated with the Sloan-Kettering Institute for Cancer Research, where he continues to advance his research and innovations. His work has the potential to significantly impact cancer treatment and improve patient outcomes.
Collaborations
Vijayasaradhi collaborates with esteemed colleagues, including Alan N. Houghton and Clarissa Naftzger, who contribute to his research endeavors.
Conclusion
Setaluri Vijayasaradhi's innovative patents and research at the Sloan-Kettering Institute for Cancer Research highlight his commitment to advancing cancer treatment. His work exemplifies the importance of innovation in the medical field and its potential to save lives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile